The Ministry of Industry and Information Technology and the National Medical Products Administration recently jointly released a list of innovative biomedical materials projects. Two titanium raw material projects from Baoji made the list, fully demonstrating the R&D and innovation capabilities of Baoji City—known as China’s Titanium Valley—in the field of biomedical materials.
The Biomedical Materials Innovation Project, as a major national innovation initiative, focuses on three key areas: polymer materials, metallic materials, and inorganic non-metallic materials. It addresses critical bottleneck technologies in the biomedical materials field by openly soliciting solutions and selecting manufacturers with core technologies and strong innovation capabilities to collaborate on breakthroughs. This approach drives industrialization advances in high-end medical materials.
Among the two titanium material projects selected in Baoji, one focuses on clinical demands for spinal orthopedic devices. Utilizing Y-type full three-roll rolling technology and atmospheric vacuum composite heat treatment, this project significantly enhances the microstructure grade, grain refinement, and process stability of titanium alloy materials for spinal implants. It has successfully broken foreign technological monopolies and filled a gap in the domestic market.
Another shortlisted project represents cutting-edge technology in the field of biomedical metallic materials. One of the projects involves ultra-fine-grained titanium wire, a critical raw material for high-end medical devices such as dental implants and orthopedic screws. Its high ductility and performance have reached advanced levels both domestically and internationally.
The successful selection of these projects will inject new momentum into Baoji’s development in the field of biomaterials, promising to propel the local titanium industry toward higher levels of advancement.